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Abstract:  All eukaryotic organisms, single-celled or multi-cellular, produce a diverse 
array of natural anti-infective agents that, in addition to conventional antimicrobial 
peptides, also include proteins and other molecules often not regarded as part of the innate 
defences. Examples range from histones, fatty acids, and other structural components of 
cells to pigments and regulatory proteins. These probably represent very ancient defence 
factors that have been re-used in new ways during evolution. This review discusses the 
nature, biological role in host protection and potential biotechnological uses of some of these 
compounds, focusing on those from fish, marine invertebrates and marine micro-algae. 
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1. Introduction 
Eukaryotic organisms, especially those from the marine environment, represent a rich hunting 
ground for the discovery of novel natural microbicidal agents. Not only do the seas contain 
representative species of nearly all the main animal taxa and a huge diversity of photosynthetic 
organisms, but they are also microbe-rich. Accordingly, over evolutionary time, marine eukaryotes 
have developed a plethora of anti-infective molecules and strategies by which they protect themselves 
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against prokaryotic and viral attack. It is no surprise, therefore, that much effort has been expended in 
identifying and characterizing antimicrobial factors from these organisms. Of the many reports that 
have been published so far, the majority have been concerned with small peptides that are often 
cationic, amphipathic and encoded by single genes. Sequence information obtained from various 
animals for over 1,500 of such proteins, known popularly as antimicrobial peptides (AMPs), are now 
lodged on databases or published in the literature. There are also some review articles [1–3]. However, 
in addition to these conventional or ‘professional’ antimicrobials are a variety of other factors 
produced by eukaryotic organisms that are not usually regarded as immune-relevant molecules but, 
nonetheless, have potent antimicrobial activities. Such factors may be molecules that serve other 
biological roles, such as maintenance of structural integrity or signalling. Alternatively they may be 
fragments derived from these proteins or lipids. Because they are unlikely to encounter opportunistic 
or invasive micro-organisms, these factors are seldom included in review articles on antimicrobial 
peptides or innate immunity. In an important early review of animal antimicrobial peptides, Hans 
Boman noted the existence of such ‘unconventional’ antimicrobial factors but did not include them 
within his four main categories of proteins distinguished on the number and type of certain residues 
and/or main structural features [4]. Rather, he combined these factors together as a miscellaneous 
group that he designated as ‘peptides or fragments derived from proteins of other function [4]. Since 
Boman’s paper was published the number of molecules now known to disrupt or kill bacterial cells has 
grown considerably.  
These unconventional antimicrobials have structural motifs that are biologically useful and which 
have been conserved during evolution. There are occasions when they might be brought into intimate 
contact with potentially harmful micro-organisms, and, thus augment the more conventional reticulo-
endothelial or mucosal immune networks. Circumstances where this might happen include mechanical 
trauma, tissue damage or controlled cell death. These are especially important for single-celled 
eukaryotes, simple-bodied marine invertebrates and deuterostomes that lack adaptive immunity 
mediated through lymphocytes and immune memory. Accordingly, the present article is aimed at 
describing some of these unconventional anti-infective agents using examples from fish, invertebrates 
and micro-algae, especially those from the sea of economic or biotechnological importance. However, 
mention is also made of antimicrobial agents from some freshwater organisms, especially fish and 
shellfish, where certain features of their microbicidal factors are relevant to similar factors in marine 
species or happen to have been studied more extensively in aquatic types.  
2. Conventional AMPs 
Conventional AMPs are broadly defined as small (<10 kDa, or ∼12–50 amino acids) cationic, 
amphipathic peptides [5]. AMPs are regarded as dedicated, ‘professional’ antimicrobial molecules, 
commonly located where they are most likely to be needed, i.e., in peripheral blood cells or epithelial 
(mucosal) surfaces. In general, AMPs are synthesized as precursors containing the active peptide 
segment, which is released by proteolytic processing, usually upon the removal of an anionic propiece 
[4]. AMPs have been described from diverse taxa throughout the animal kingdom although, amongst 
marine and aquatic species, their most frequent identification has been in fish and shellfish (Table 1), 
reflecting the high level of interest given to economically important animals. Mar. Drugs 2010, 8        
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Table 1. Major conventional AMPs/AMP families isolated from marine invertebrates and 
fish: distribution across phyla. 
Taxon   Peptide/peptide family  Key reference 
Cnidaria (Scyphozoa)  Aurelin Ovchinnikova  et al. [6] 
Annelida (Polychaeta)  Arenicin 
Hedistin  
Perinerin 
Ovchinnikova et al. [7] 
Tasiemski et al. [8] 
Pan et al. [9] 
Mollusca (Bivalvia)  Big defensins 
1 
Cg-prp   
Defensins 
1 
Myticins 
1  
Mytilins 
1  
Mytimycin  
Li et al. [10] 
Li et al. [10] 
Li et al. [10] 
Li et al. [10] 
Li et al. [10] 
Li et al. [10] 
Crustacea (Decapoda)  Arasin-1  
Bac-like 
Callinectin 
Crustins 
1 
Homarin 
Hyastatin 
Penaeidins 
1 
Scygonadin 
Scylla serrata antimicrobial protein 
Stensvåg et al. [11] 
Schnapp et al. [12] 
Khoo et al. [13] 
Smith et al. [14] 
Battison et al. [15] 
Spersted et al. [16] 
Cuthbertson et al. [17] 
Huang et al. [18] 
Yedery and Reddy [19] 
Chelicerata  Big defensin 
Polyphemusins 
1 
Tachycitin 
Tachyplesins 
1 
Tachystatins 
1 
Saito et al. [20] 
Miyata et al. [21] 
Kawabata et al. [22] 
Miyata et al. [21] 
Osaki et al. [23] 
Echinodermata 
(Echinoidea) 
Strongylocins 
1 Li  et al. [24] 
Urochordata 
(Ascidiacea) 
Clavanins 
1 
Dicynthaurin 
Halocidin 
Halocyamines 
1 
Halycyntin 
Papillosin 
Styelins 
1  
Lee et al. [25] 
Lee et al. [26] 
Jang et al. [27] 
Azumi et al. [28] 
Galinier et al. [29] 
Galinier et al. [29] 
Lee et al. [30] 
Chordata (Pisces)  Cathelicidins 
1 
Defensins 
1 
Hepcidins 
Liver-expressed antimicrobial  
peptides (LEAPs) 
1 
Piscidins 
1 
Smith and Fernandes [31] 
Smith and Fernandes [31] 
Smith and Fernandes [31] 
Smith and Fernandes [31] 
 
Smith and Fernandes [31] 
1 Family of peptides as opposed to a single novel protein. 
The first AMPs from aquatic animals were identified as proteins on the basis of their antimicrobial 
activity during biochemical purification [12,25,28], while more recently, putative novel AMPs have Mar. Drugs 2010, 8        
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been found by molecular techniques such as expressed sequence tag (EST) analyses and gene   
cloning [32,33]. A definitive classification scheme still needs to be agreed but most authorities 
recognise at least 3 main classes of conventional AMPs based on their secondary structure, namely: 
linear  α-helical peptides; cysteine-rich peptides containing β-sheets and disulphide bonds; certain 
amino acid enriched peptides (Table 2). As might be expected, given their extremely diverse sources, 
not all peptides necessarily fit into clear categories and therefore, for the purposes of this review, these 
are grouped separately into a further miscellaneous category (Table 2).  
For all conventional AMPs, features such as size, charge, conformation/secondary structure, 
hydrophobicity and amphipathicity are critical in determining antibacterial activity and modes of 
killing and have been well reviewed previously [34]. However, the precise mechanisms of   
peptide-membrane interactions and bacterial killing for many AMPs are often unconfirmed, 
particularly for those from marine sources. In general, killing relies on the initial attraction of the 
peptide to the bacterial surface and its subsequent attachment and interaction with the cytoplasmic 
membrane [35,36]. Attraction is largely mediated by the electrostatic interaction between the 
positively-charged peptides and the negatively-charged molecules of the bacterial cell wall. Following 
this, killing is dependent on AMP insertion into, and permeabilization of, the cytoplasmic membrane 
via various mechanisms [35,36]. Three main mechanisms have been proposed to explain this, which 
are the barrel-stave, toroidal pore and carpet models. These have been described and illustrated 
elsewhere [34]. The barrel-stave model describes pore formation by the alignment of the hydrophobic 
peptide regions with the bacterial membrane lipid head groups, with the AMP aligned parallel with the 
membrane surface [37]. Repositioning of the AMP perpendicular to the membrane creates the pore, of 
which the hydrophilic regions of the AMP form the pore interior [37]. However, this model has been 
confirmed for only a small number of peptides (e.g., alamethicin from the fungus, Trichoderma viride [37]). 
The formation of toroidal pores again relies on AMPs binding to lipids, but this time the association 
causes the bacterial membrane to bend inwards through the pore, retaining some association of the 
AMP-pore components with the lipid head groups of the bacterial membrane (e.g., the fish AMP 
piscidin from the striped bass, Morone saxatilis x M. chrysops [38]). The carpet mechanism operates 
through AMPs aggregating on the bacterial membrane and disrupting the bilayer in a detergent-like 
fashion, which leads to the formation of micelles (e.g., dermaseptin from the frog genus   
Phyllomedusa [35]). A few AMPs, such as the amphibian peptide buforin II, can translocate across the 
membrane without permeabilization and subsequently act on intracellular targets [39]. Otherwise there 
is very little known of the mechanisms of action of individual conventional AMPs from marine 
organisms and this is in urgent need of clarification.  
After initial membrane disruption has taken place, killing may proceed by a number of ways. The 
most commonly assumed mechanism is direct cell lysis via membrane rupture, however, other possible 
mechanisms include inhibition of cell wall, protein or nucleic acid synthesis (e.g., tachyplesin from the 
horseshoe crab [40] and pleurocidin from the winter flounder, Pleuronectes  americanus [41]), 
inhibition of enzyme activity (e.g., human histatins [42]), and binding to heat shock proteins and other 
chaperones (e.g., the bee AMP apidaecin [43]), which prevents the repair or elimination of misfolded 
and damaged proteins. The antimicrobial activity of AMPs has been quantified using a huge diversity 
of bacteria and a number of different methods. A standard way of expressing antimicrobial activity is 
the minimum inhibitory concentration (MIC), which is the lowest concentration of a peptide that Mar. Drugs 2010, 8        
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inhibits the growth of bacteria after a predetermined incubation time, typically 24 hours. Other 
measures commonly used are the concentration that inhibits 50% of bacterial growth (IC50) and 
percentage growth inhibition. In the following sections, conventional AMPs from marine and aquatic 
animals are described according to the structural classification scheme in Table 2. 
Table 2. Distribution of conventional AMPs/AMP families into structural categories.  
Categories of AMPs  Examples  Activity 
1 
Linear, α-helical  Clavanins (Ascidians)  G+, G–, F 
Dicynthaurin (Ascidians)  G+, G–, H 
Halocyntin (Ascidians)  G+, G– 
Papillosin (Ascidians)  G+, G– 
Piscidins (Fish)  G+, G–, F, H 
Styelins (Ascidians)  G+, G–, H 
Cysteine-rich No.  disulphide 
bonds 
  
   2  Cathelicidins  (Fish)  G+,  G– 
LEAPs (Fish)  G–, F 
Tachyplesins (Horseshoe crabs)  G+, G–, F 
Polyphemusins (Horseshoe crabs)  G+, G–, F 
   3  Aurelin  (Jellyfish)  G+,  G– 
Big defensins (Horseshoe crabs)  G+, G–, F 
Penaeidins (Shrimp)  G+, G–, F, Cb 
Strongylocins (Sea urchins)  G+, G– 
Tachystatin (Horseshoe crabs)  G+, G–, F, H 
2, Cb 
   4  Defensins  (Molluscs)  G+,  G–
3, F 
LEAPs (Fish)  G–, F  
Myticins (Molluscs)  G+, G–
4, F 
4 
Mytilins (Molluscs)  G+, G–, F 
5 
Crustins (WAP domain; crabs)  G+ 
      5  Tachycitin (Horseshoe crabs)  G+, G–, F, Cb 
Cationic peptides: specific amino 
acid enriched 
Arasin-1 (Spider crab) (proline and arginine rich) 
Bac-like (Crab) (proline rich) 
Cg-prp (Oyster) (proline rich) 
 
Hyastatin (Spider crab) (glycine rich) 
Penaeidins (Shrimp) (proline and cysteine rich) 
G+, G– 
G+, G– 
Synergises with 
defensin 
G+, G–, F, Cb 
G+, F, Cb 
Miscellaneous Arenicin  (Polychaete) 
Hedistin (Polychaete) 
Perinerin (Polychaete) 
G+, G–, F 
G+, G– 
G+, G–, F 
1 G+, Gram-positive; G–, Gram-negative; F, Fungi; H, haemolytic; Cb, chitin-binding; 
2 Tachystatin C only;  
3 Defensin from Crassostrea virginica; 
4 Myticin B isoform; 
5 Mytilin isoforms B & D. 
2.1. Linear, α-helical peptides 
This peptide class comprises short, linear structures that have spatial segregation of hydrophobic 
and hydrophilic residues, with the peptides adopting an α-helical conformation when interacting with Mar. Drugs 2010, 8        
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bacterial membranes. These peptides are extremely widespread throughout non-marine animal taxa 
and were first recorded in amphibians (magainins) and insects (cecropins) but amongst marine and 
aquatic animals their distribution to date appears mainly among ascidians and fish (Table 2). However, 
the peptide homarin, identified in the lobster, Homarus americanus, has sequence similarity with the 
short, linear α-helical temporins from the European red frog, Rana temporaria, but further information 
is needed to confirm the secondary structure of homarin [15]. 
2.1.1. Invertebrates 
The α-helical ascidian peptides include the clavanins and styelins, both groups purified from the 
haemocytes of Styela clava [25,30]. The four native clavanins are 23-residue, 2.6 kDa AMPs that 
possess rapid, broad-spectrum antimicrobial activities, inhibiting the growth of Gram-negative 
(Escherichia coli) and Gram-positive (Listeria monocytogenes) bacteria, as well as the fungus, 
Candida albicans [25]. Synthetic clavanin A is bactericidal against E. coli and L. monocytogenes at  
<4 µg mL
−1 within 5 minutes of incubation. Clavanins are unusual in that they are histidine-rich and 
synthetic versions show different modes of antimicrobial activity at different pH values with greater 
potency under mildly acidic (5.5) pH compared with neutral pH [44]. At pH 7.0 killing is dependent on 
non-specific membrane disruption but at lower pH the histidines become protonated and membrane 
disruption probably occurs through interaction with the proteins responsible for generating ion 
gradients [45]. Clavanins retain their antimicrobial activity at high NaCl concentrations [44]. 
Styelins were also isolated from S. clava and comprise five 3.7 kDa phenylalanine-rich   
peptides [30,46]. Two were purified directly from the haemocytes [30] with an additional three 
members identified by molecular methodologies [46]. One of these, styelin D, was subjected to 
detailed analyses which reveal that it has potent activity against Gram-positive bacteria (MICs   
∼5–7 μg mL
−1) at pH values from 5.5–7.4 [47]. It is also active against Gram-negative bacteria at pH 
5.5 (MIC 2.1 μg mL
−1) [47]. Styelins are active at high salt concentrations and the characterization of 
styelin D reveals that it contains an unusually high number of post-translationally modified residues 
that are thought to facilitate the antimicrobial activity in high salt and acidic pH conditions [47].  
Other ascidian AMPs that form α-helical structures include dicynthaurin, a peptide from 
Halocynthia aurantium that forms a homodimer consisting of two, 30-residue monomers and has a 
single cysteine residue [26]. Unusually for an AMP purified from a marine animal, and in contrast to 
the clavanins and styelins, dicynthaurin is more potently antimicrobial at low salt concentrations, 
which indicates that the peptide might be compartmentalised in the cell [26]. A dimer structure also 
exists in halocidin from Halocynthia papillosa, although the peptide is a heterodimer consisting of one 
18- and one 15-residue monomer linked by a disulphide bond [27]. Recently, two new AMPs, 
halocynthin and papillosin, have been isolated from H. papillosa [29]. Both of these AMPs are active 
against Gram-positive and Gram-negative bacteria [29].  
2.1.2. Fish 
Alpha-helical amphipathic peptides are very common in fish as recently reviewed by Smith and 
Fernandes [31]. The first fish family of AMPs to be discovered was the α-helical pardaxins. These 
were isolated from the skin glands of Red Sea Moses sole, Pardachirus marmoratus, on the basis of Mar. Drugs 2010, 8        
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their cytotoxic, pore-forming activities [48,49]. Pardaxins were originally described as toxins with 
anti-predatory function but subsequently they have been found to be active against Gram-positive and 
Gram-negative bacteria [50].  
However, most fish α-helical peptides are members of the piscidin family, which includes the 
pleurocidins and piscidins [31]. Pleurocidins are 25-residue peptides first isolated from the skin mucus 
of winter flounder, Pleuronectes americanus. [51]. They have broad-spectrum antimicrobial   
activities [51] and inhibit DNA, RNA and protein syntheses [41]. Piscidins are 22-residue peptides 
first purified from skin and gills of hybrid striped bass (M. saxatilis x M. chrysops) [52] and now 
known to be present in other Perciformes [53]. Also within the piscidin family are dicentracin from the 
European bass, Dicentrarchus labrax [54], chrysophsins from red sea bream, Chrysophrys major [55] 
and epinecidin from the orange-spotted grouper, Epinephelus coioides [56]. All piscidins show   
broad-spectrum antimicrobial activity, probably killing cells via toroidal-pore formation [38,57–59]. 
Lee  et al. [60] determined the solution structure of piscidin-1 and established that it is the 
conformational flexibility at the boundary between the hydrophobic and hydrophilic regions that is the 
critical factor for membrane selectivity and antibacterial activity. Recently, piscidin-2 has been found 
to cause cell membrane damage to three fungal strains known to cause infections in humans [61]. 
Importantly, they are expressed in mast cells [57], granules of acidophilic phagocytes and in gill, skin, 
stomach and intestinal epithelia [53]. In gilthead seabream, they are stored in the granules of the 
phagocytes and are delivered to the phagosome following uptake of bacteria by these cells [53]. 
Although attractive as potential candidates for topical application use because of their activity at high 
salt concentrations [52], the disadvantage of piscidins in this respect is their haemolytic and cytotoxic 
properties [57]. 
2.2. Cysteine-rich peptides 
This group of conventional AMPs contains representatives from bivalve molluscs, decapod 
crustaceans, horseshoe crabs and fish (Table 2). The most prominent group of cysteine-rich AMPs is 
the defensins. These are defined as peptides with characteristic β-sheets and a precise arrangement of 6 
cysteines forming three disulphide bonds [62]. However, with the increasing rate of discovery of new 
AMPs from invertebrates, there are a number of peptides which do not fit the standard defensin 
definition (e.g., the MGD-1 peptide from Mytilus galloprovincialis; [63]), yet share the cysteine-rich, 
β-sheet or disulphide bond features of the group. Such peptides also include the large family of 
crustins, which are cysteine-rich (containing eight cysteines) yet are characterized by the possession of 
a 4-disulphide core, rather than classical β-sheet arrangements with six cysteines [14].  
2.2.1. Invertebrates  
The first groups of cysteine-rich AMPs to be purified from invertebrates are the tachyplesins, 
polyphemusins, tachystatins, big defensin and tachycitin, all from the horseshoe crabs, Tachypleus 
tridentatus or Limulus polyphemus, as reviewed by Iwanaga [64]. Features shared by these peptides 
include broad-spectrum antimicrobial activities, strong amphipathicities, the presence of β-sheets and 
β-turns and two or more disulphide bonds [64]. The tachyplesins are 17-residue AMPs that contain an 
anti-parallel  β-sheet linked by a β-turn, and two disulphide bonds [21,64]. The tachyplesins bind Mar. Drugs 2010, 8        
 
1220
lipopolysaccharide (LPS) [21] and target the bacterial inner membrane by altering potassium 
permeability [65]. Their MICs range from 0.8–12.5 μg mL
−1 against susceptible bacteria and fungi [21]. 
The polyphemusins are 18-residue peptides that share with tachyplesins both β-sheets, β-turn and two 
disulphide bonds [21]. Polyphemusins have antimicrobial activity spectra that are similar to the 
tachyplesins, with MICs ranging from 3.1–12.5 μg mL
−1 [21]. 
The tachystatins of horseshoe crabs are AMPs that bind chitin, possess 3 disulphide bridges and a 
3-stranded β-sheet, stabilized by cysteine residues [66]. The tachystatins share structural similarity 
with ω-agatoxins (venoms isolated from the funnel web spider) that also bind chitin and have weak 
antifungal properties [66]. The antifungal activities of tachystatins and ω-agatoxins are mediated by 
their chitin-binding properties but the weaker activities of ω-agatoxins (IC50 values of 0.5 and   
7.8 µg mL
−1, respectively) probably arise from the lack of strong amphipathic conformation [66]. 
Another horseshoe crab AMP that binds chitin is tachycitin, a 73-residue AMP containing five 
disulphide bonds [67]. The structure of tachycitin includes a β-hairpin loop with a 2-stranded β-sheet, 
and shares some sequence similarity to the hevein domain (a domain that is characteristic of peptides 
which bind chitin and have antimicrobial activities [67]).  
The big defensin of horseshoe crabs has 79 amino acid residues and three disulphide bonds with the 
disulphide motif identical to the β-defensins of bovine neutrophils [20]. The N- and C-termini of the 
big defensin show differential antimicrobial activities and, while the N-terminus is highly active 
against Gram-positive bacteria, the C-terminus is most potent against Gram-negative species [20]. The 
big defensin has an unusual structure, containing three α-helices, a double-stranded parallel β-sheet at 
the N-terminus and a four-stranded anti-parallel sheet at the C-terminus, thus creating two distinct 
domains [68]. The N-terminus domain has a β1-α1-α2-β2 fold and contains a hydrophobic core, while 
the C-terminus comprises a β3-β4-β5-α3-β6 domain that adopts a compact structure held by its 
disulphide bonds [68]. The differential antimicrobial activities of the N- and C-termini are thought to 
arise from proteolytic cleavage by microbial proteinases, since cleavage with trypsin liberates the 
hydrophobic N and the cationic C-terminus fragments [68]. Recently, a big defensin gene (AiBD) has 
been cloned from the bay scallop, Argopecten irradians [69]. The deduced amino acid sequence of this 
gene shares 48% identity with the horseshoe crab big defensin [69]. The arrangements and spacings of 
the cysteine residues are highly conserved between these two AMPs, while a recombinant AiBD 
protein has a similar spectrum of antimicrobial activity to the horseshoe crab peptide [69]. 
Among the invertebrate cysteine-rich AMPs are also the defensins, myticins, mytilins and 
mytimycin, purified from the haemocytes of marine mussels belonging to the genus, Mytilus (M. edulis 
and M. galloprovincialis). These AMPs have been subjected to the most detailed investigations of all 
bivalve peptides reported to date [10]. All the Mytilus spp. AMPs are amphipathic and have 
hydrophobic and cationic features, although there are variations in their structures and activities [10]. 
Whereas the M. edulis defensin has six cysteines like the arthropod defensins [70], the defensin 
purified from M. galloprovincialis (MGD-1) has eight cysteines arranged in four disulphide bonds 
[63]. MGD-1 is principally active against Gram-positive bacteria [71] and contains the cysteine-
stabilized  
α-β motif (CSαβ; [72]). Its antimicrobial activity is dependent on the β-hairpin loop that is involved in 
binding, growth inhibition and bacterial membrane permeabilization [71]. In contrast to the insect 
defensins, neither the defensin nor mytilin B from M. galloprovincialis appear to be inducible, as Mar. Drugs 2010, 8        
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transcription appears to decrease with bacterial challenge, although plasma levels of the peptide 
increase [73,74]. 
The peptides in the myticin family are structurally similar to the Mytilus spp. defensins in that they 
have eight cysteine residues, comprising four disulphide bonds, and are potently active against   
Gram-positive bacteria [75]. The mytilin peptides exhibit diverse antimicrobial spectra depending on 
their different isoforms. Of the five mytilin isoforms so far purified from Mytilus spp., three (B, C and D) 
are active against Gram-positive and Gram-negative bacteria, one (G1) is active only against   
Gram-positive strains, while two (B and D) are also antifungal [74]. Recently the full structure of 
synthetic mytilin was found to share similarities with MGD-1 as both peptides contain the CSαβ motif, 
although the N-terminus section of mytilin is shorter and the β-hairpin more extensive in the mytilin 
peptide [76]. The antifungal peptide mytimycin from M. edulis has received less attention compared 
with the other Mytilus spp. AMPs, but is ∼6.5 kDa and is thought to contain 12 cysteines [70]. In 
comparison with other marine invertebrates, Mytilus spp. AMPs have been the best studied with 
respect to their localization in cells and tissues, their expression under different conditions [77] and 
during their life-history [78], their differential involvement in antimicrobial defence [79] and the 
distribution of different isoforms in individual animals [80]. 
Defensins have also been purified from the gills of the American oyster, Crassostrea virginica [81] 
and identified at the molecular level from the mantle tissue and haemocytes of the Pacific oyster, 
Crassostrea gigas [32,33]. Like the Mytilus spp. defensins, the defensins from C. gigas have eight 
cysteines, the CSαβ motif and are principally active against Gram-positive bacteria [32]. The   
38-residue defensin from C. virginica has high sequence homology (62%–73%) with the arthropod 
defensins, has six cysteines and is active against both Gram-positive and Gram-negative bacteria [81]. 
A few AMPs have been reported from clams, scallops and abalone, but as most of these have arisen 
from molecular methodologies relatively little is known about the features or activities of either native 
or recombinant peptides [10]. 
The two main families of cysteine-rich AMPs from crustaceans are the crustins [14] and   
penaeidins [17]. Carcinin, the first crustin to be discovered, was purified from the shore crab, Carcinus 
maenas [82], however it was not designated a crustin until much later [83]. Crustins have been found 
in every decapod crustacean studied, with gene sequences similar to crustins also present in the 
amphipod, Gammarus pulex, the brine shrimp, Artemia salina, and the copepod, Calanus finmarchius 
as discussed by Smith et al. [14]. Although first identified by their antimicrobial activities, the crustins 
are not especially potent nor do they exhibit broad-spectra antimicrobial activities, as they tend to 
affect mainly Gram-positive bacteria. Smith et al. [14] define crustins as cationic, cysteine-rich 
antibacterial polypeptides, ∼7–14 kDa, containing one whey four-disulphide core domain (WFDC; 
also known as a WAP domain), a conserved structure of eight cysteines forming a 4-disulphide core at 
the C-terminus. In addition, Smith et al. [14] propose that three types of crustin (I, II, III) exist, each 
distinguished by the domain structure between the signal sequences and the C-terminus domain 
containing the WFDC. All three types possess a signal sequence at the N-terminus and the WFDC 
domain at the C-terminus [14]. The WFDC domain is tightly constrained by three disulphide bonds 
and has a small α-helix that probably accounts for the antibacterial effect of the crustins. As well as the 
WFDC domain, Type I crustins also possess a cysteine-rich domain that contains six cysteines [14]. 
Type II crustins have yet another domain, rich in glycines between the signal sequence and the six Mar. Drugs 2010, 8        
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cysteine-region [14]. Type III crustins have neither the glycine- nor cysteine-rich domains [14]. It has 
been suggested that the crustins could have other roles in the normal physiology of the animals, as 
carcinin expression can change with varying environmental factors and with the moult cycle of the 
crab, yet shows little change in expression when subject to bacterial challenge [14].  
The penaeidins, first identified from the shrimp Litopenaeus vannamei, [84] have now been isolated 
from a number of shrimp species [17]. Their distribution appears to be confined to shrimp unlike the 
crustins, which are present in shrimp as well as all other decapods [14]. Penaeidins are 5–6 kDa and, in 
addition to the signal sequence, they comprise two domains: a proline-arginine rich N-terminus and a 
cysteine-rich (typically six cysteine residues) C-terminus. Of the two domains, the cysteine-rich one is 
more compact and includes an α-helix, stabilized by three disulphide bonds. Five families of 
penaeidins have been classified to date, with their spectra of activities predominantly against   
Gram-positive bacteria and fungi [84]. Penaeidins have chitin-binding activity, which is also attributed 
to the C-terminus region, but the presence of a specific domain, such as a hevein domain, has not been 
confirmed [85].  
A few cysteine-rich peptides have been purified from other invertebrate groups, e.g., aurelin from 
the jellyfish, Aurelia aurita [6]. Aurelin contains six cysteines forming three disulphide bridges and 
comprises a signal peptide, anionic propiece and a mature cationic part, thus resembling certain 
structural features of the defensins [6]. Unlike the defensins the distribution of cysteine residues is 
more reminiscent of the potassium-blocking channels of sea anemone toxins, although such a property 
in aurelin has yet to be investigated [6]. Aurelin is active against Gram-positive and Gram-negative 
bacteria, with MICs ranging from 7–22 µg mL
−1 [6].  
The first AMPs to be isolated from any echinoderm are the strongylocins from the sea urchin, 
Strongylocentrotus droebachiensis [24]. These are cationic cysteine-rich peptides (5.6 and 5.8 kDa) 
that contain six cysteines likely to form three disulphide bonds, although the cysteine arrangement 
patterns differ from those observed in other AMPs with six cysteines [24]. Strongylocins exert 
antimicrobial activities against both Gram-positive and Gram-negative bacteria (IC50 ranging from 
1.3–5 µM) and they contain bromotryptophan; a feature they share with some other AMPs from 
marine sources [24] (e.g., hedistin [8]).  
2.2.2. Fish 
Amongst the cysteine-rich AMPs in teleost fish are three families: cathelicidins, defensins and   
LEAPs [31]. By screening cDNA libraries, putative cathelicidins have been found from rainbow trout, 
Oncorhynchus mykiss [86] and an EST database of Atlantic salmon, Salmo salar [87]. Using molecular 
methodology, further cathelicidins have been identified for Arctic char, Salvelinus alpines, Atlantic 
cod, Gadus morhua, and brook trout, Salvelinus fontinalis [88]. Moreover, cathelicidin genes have 
been reported for jawless fish, namely the Atlantic hagfish, Myxine glutinosa [89]. The structures of 
teleost cathelicidins have some features in common with mammalian cathelicidins, e.g., the presence 
of four cysteines at the C-terminus regions forming two disulfide bonds [87]. However, in general, the 
signal peptides of teleost cathelicidins tend to have fewer amino acid residues but a longer cathelin-like 
domain than mammals [87]. Little information is available with respect to the native peptides but Mar. Drugs 2010, 8        
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synthetic rainbow trout cathelicidins are active against Gram-positive and Gram-negative   
bacteria [87].  
Defensins from teleost fish, as with cathelicidins, have been identified by molecular methodologies 
rather than purification of the native peptides. Zhou et al. [90] used EST and complete genome data to 
identify defensins from zebrafish and pufferfish that resemble the β-defensins of birds and mammals. 
The fish defensins contain six conserved cysteines in the region of the mature peptide and three   
β-strands, although one difference to the avian and mammalian defensins is the presence of an extra 
helix in one of the zebrafish peptides [90]. Falco et al. [91], using a recombinant protein based on 
rainbow trout defensin, found it to be antiviral against viral haemorrhagic septicaemia rhabdovirus 
(VHSV), one of the most troublesome diseases in fish aquaculture. More recent studies have cloned 
three novel β-defensins from rainbow trout, all of which appear to be constitutively expressed but 
increase in expression during bacterial and simulated viral challenges [92]. Similarly, a β-defensin-like 
gene from the olive flounder, Paralichtyus olivaceus, has been identified, which is expressed in larval 
fish just one day after hatching, although the expression declines between 1–35 days post-hatching [93]. 
Moreover, β-defensin expression in juvenile fish is induced under conditions of bacterial challenge and 
the recombinant peptide suppresses the growth of E. coli [93].  
The last major group of cysteine-rich AMPs from fish is the LEAPs (liver-expressed antimicrobial 
peptides) [31], the acronym reflecting the original identification of the peptide family in the human 
liver [94]. Peptides belonging to the LEAP family include hepcidins from several species (e.g., winter 
flounder, turbot and red sea bream), Sal-1 and Sal-2 from Atlantic salmon, JF-1 and JF-2 from 
Japenese flounder, and LEAP-2 from catfish and trout (reviewed by Smith and Fernandes [31]). The 
first fish LEAP to be identified, the hepcidin from the gills of striped bass [95], has a similar structure 
to human hepcidin and consists of two anti-parallel β -sheets and eight cysteines forming four 
disulphide bonds [96]. However, two LEAPs have since been found that only possess two disulphide 
bonds [31]. Their activity spectra have been determined mainly using synthetic peptides, which show 
activity against Gram-negative bacteria and fungi [96]. Under conditions of bacterial challenge, the 
expression of hybrid bass hepcidin is detectable in most tissues, but is highly up-regulated in the liver 
(>4,000 fold) [95]. Some fish LEAPs, e.g., those from catfish and turbot, are expressed very early in 
the life cycle in comparison with other fish AMPs and their involvement in iron regulation has also been 
suggested [31]. 
2.3. Cationic peptides, amino acid enriched 
None of the known fish AMPs are classified as amino acid enriched cationic peptides [31]   
(Table 2). Cationic, amino acid enriched peptides from marine invertebrates include the proline-rich 
peptide, Bac-like, isolated from the shore crab, Carcinus maenas [12] and the partial sequence of a 
proline-rich peptide (callinectin) from the blue crab, Callinectes sapidus [13]. In addition, molecular 
techniques have enabled the identification of a proline-rich peptide (Cg-prp) from the Pacific oyster, 
C. gigas [97] (Table 2). The Bac-like peptide from C. maenas has activity against both Gram-positive 
and Gram-negative bacteria and has some functional and partial sequence similarity to bovine 
cathelicidin AMPs e.g., bactenecin-7 [12]. The callinectin AMP is active against E. coli and has a 
hydrophobic region but the proline residues are arranged differently compared with existing proline-Mar. Drugs 2010, 8        
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rich AMP sequences [13]. Cg-prp was originally identified from EST data but synthetic fragments 
show weak antimicrobial activites [97].  
Further examples of amino acid enriched AMPs from marine invertebrates include aracin and 
hyastatin, from the spider crab, Hyas arenaeus, both of which contain more than one distinct domain. 
Aracin is a 37-residue AMP, which has an N-terminus enriched for proline and arginine and a C-terminus 
containing four cysteines forming two disulphide bridges [11]. The native peptide is active against both 
Gram-positive and Gram-negative species, with IC50 values ranging from 0.8–12.5 µM [11] (Table 2). 
Hyastatin, an 11.7 kDa glycine-rich AMP, possesses a domain at the C-terminus containing six 
cysteines arranged in a similar three disulphide bond formation to that of the penaeidins [16]. This 
AMP is active against Gram-positive and Gram-negative bacteria as well as fungi, with IC50 values 
ranging from 0.4–12.5 µM [16] (Table 2). Activity against Gram-positive bacteria is severely reduced 
in the recombinant peptide by removal of the cysteine region [16]. Both native hyastatin and its   
N-terminus region can bind chitin, which may facilitate its antifungal capability or suggest a more 
multi-functional role in the animal [16].  
2.4. Miscellaneous AMPs 
Three novel AMPs have been purified from marine worms. Two isoforms of the AMP, arenicin, 
have been purified from the immune cells of the lugworm, Arenicola marina [7]. The arenicins are  
21-residue peptides containing 2-stranded β-sheets as well as one disulphide bridge forming an   
18-residue ring [7]. They are regarded as a new class of AMP largely because of the ring structure [7]. 
They possess strongly hydrophobic regions separated by positively charged arginine side chains and 
the presence of arginine is thought to contribute to high salt tolerance [98]. Arenicins completely kill  
E. coli within 5 minutes at a concentration of 5 µM probably by membrane permeabilization [98] 
(Table 2). A second annelid peptide, named perinerin, has been purified from the clamworm, 
Perinereis aibuhitensis [9]. Perinerin contains four cysteine residues forming two disulphide bridges 
with the most abundant amino acid being arginine [9]. This peptide was not classed as being highly 
enriched for any amino acid and despite the presence of cysteine residues and disulphide bridges, its 
average percentage identity to other cysteine-rich AMPs was less than 30% [9]. Perinerin is active 
against Gram-positive (lowest MIC is 1.5 μg mL
−1) and Gram-negative (lowest MIC is 3.1 μg mL
−1) 
bacteria, as well as the fungus, Paecilomyces heliothis (MIC 12.5 μg mL
−1) [9] (Table 2).  
Finally, the most recent AMP to be isolated from a marine annelid is hedistin purified from the 
ragworm, Nereis diversicolor [8]. It shares no significant similarity with other AMPs [8]. Both native 
and synthetic hedistins are active against Gram-positive and Gram-negative bacteria with MICs as low 
as 0.4–0.8 µM (Table 2). Hedistins are notable for containing bromotryptophan, although the synthetic 
version without bromines is still effective, indicating that bromination is not essential for activity [8]. Mar. Drugs 2010, 8        
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3. Unconventional Anti-infectives 
3.1. Antimicrobials derived from intracellular structures 
3.1.1. Histones 
Histones are proteins present in the nuclei of all eukaryotic organisms. They are conspicuous 
proteins of chromatin and are responsible for the packaging of DNA, essentially serving to wind up the 
long DNA strands in a spool-like manner. There are several types of histone of which H2A, H2B, H3 
and H4 are the core histones that form the nucleosome, and H1 and H5 are the linker histones. That 
histones have potent antimicrobial properties has been known for over 50 years [99] but at that time 
there was no theoretical concept as to how they might interact with bacteria for the host’s benefit, so 
little attention was paid to this discovery. By the late 1990s, histones were reported to contribute to the 
antibacterial activity of wound blister fluid [100]. Then reports began to emerge that histones account 
for a large proportion of the antibacterial activity of skin exudates from amphibians [101] and teleost 
fish [102–105]. Noga et al. [106] also found that histones are active against fish-parasitic 
dinoflagellates. Histones have now been reported to be present in the skin mucus of several fish taxa, 
including Salmoniformes, Siluriformes and Pleuronectiformes [31] (Table 3).  
Amongst the core histones, H2A is a potent antibacterial agent. It is a 13.6 kDa protein able to kill 
Gram-positive bacteria at sub-micromolar (<0.4 μM) concentrations within 30 minutes in vitro [105]. 
It also has some weak activity against the yeast, Saccharomyces cerevisiae, but it is not haemolytic to 
trout erythrocytes at antimicrobial concentrations [105]. It does not appear to form stable ion channels 
in the bacterial cell membrane but reconstituting pure H2A in a planar lipid bilayer does disturb the 
membrane [105]. Interestingly, it is not only the intact H2A protein that has antimicrobial effects but 
also fragments generated from the N-terminus by proteolytic cleavage (Table 3). Such fragments 
include parasin-1 from the catfish, Parasilurus asetu, [101], hipposin from Atlantic halibut 
Hippoglossus hippoglossus [109], buforins from toads [114], and abhisin from abalone [110]. H2A or 
fragments derived from it have also been recorded for scallop, Chlamys farreri [115] and shrimp, 
Litopenaeus vannamei [108] (Table 3). The liberation of parasin-1 from H2A in fish mucus is 
mediated through the enzyme cathepsin D [116] with a second enzyme, matrix metalloproteinase 2, 
involved in the regulation of this process [117].  
Core histone H2B also has antimicrobial activity, which was first noted for mouse macrophages [118] 
and subsequently reported for channel catfish skin exudates [102], epidermal secretions from Schlegel’s 
Green tree frog [119], surface mucus from Atlantic cod [111] and shrimp haemocytes [108] (Table 3). 
Histone H2B is active against the fish pathogens, Aeromonas hydrophilia and Saprolegnia [102]. Histone 
H4 is another microbicidal core histone, having been found to be one of the active factors in human 
sebocyte secretions [120]. H4 from shrimp haemocytes has antibacterial properties [108] but reports 
for its antimicrobial role in other marine or aquatic organisms are scant. With H3, synthetic H3–like 
peptides are antibacterial [121] and H3 is present in mucus extruded from the hagfish   
Myxine glutinous [122]. 
The linker histones also have anti-infective properties (Table 3). H1 exhibits antimicrobial 
properties and has been isolated from several species, including humans [123], mice [118],   
fish [104,107,124] and shrimp [108]. H1, when isolated from Coho salmon, is active against E. coli Mar. Drugs 2010, 8        
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with a MIC of 31 μg mL
−1 [104]. A 26-residue N-terminus fragment of H1 from Coho salmon is also 
active against various fish pathogens, including Aeromonas salmonicida, Listonella anguillarum and 
Salmonella enteritica [103]. In winter flounder, the expression of this protein is up-regulated following 
immune stimulation, which coincides with an increase in the antibacterial activities of serum and 
mucus [103], indicative of its role in systemic as well as mucosal response to non-self challenge. 
Significantly, the C-terminus from H1 (from O. mykiss) has been shown to generate a 7.2 kDa 
fragment, termed oncorhyncin II, that has very high potency (∼10 times greater than cecropin P1) 
against both Gram-positive and Gram-negative bacteria, probably by destabilizing the bacterial 
membrane, although not necessarily by pore formation [107]. Therefore, H1 is strongly antibacterial 
not only as the complete molecule but through fragments at both the N and C-termini (Table 3). 
Histones are highly conserved alkaline and water soluble proteins showing remarkable similarity 
across divergent phyla. For example, antisera to human histones are known to cross react with histones 
from several invertebrates [125]. It is therefore highly likely that histones from most, if not all 
eukaryotic species, will show similar potent antimicrobial activity as those described above, although 
the extent and modes of histone participation in host defence is, as yet, far from clear. Their possession 
of amphipathic secondary structures and microbicidal properties might be merely incidental and have 
no survival value. Hirsch’s finding in 1958 [99] of the antimicrobial properties of histones was 
disregarded as not physiologically relevant for many years but the presence of these peptides in skin 
secretions of fish is less surprising given that fish skin is living and not keratinized. The epithelial 
surface is constantly at risk of abrasion and sloughing, so damage to the cells from such minor injuries 
might permit histones and other intracellular antibacterial proteins, along with phospholipid-derived 
free fatty acids, to become exposed to epibionts or potential invaders from the surrounding water. 
Enzymes, such as cathepsin D, also expressed in fish epidermal mucosa, are now known to aid the 
release of histone fragments [116]. However, this does not explain how histones or other intracellular 
antibacterial factors might interact with infectious agents within the body tissues of any animal. 
3.1.2. Other intracellular proteins 
Apart from the core and linker histones, research on rainbow trout has established that other 
intracellular proteins have potent antibacterial activities against infectious agents. One from fish is a  
6–7 kDa N-terminus fragment of a high mobility non-histone chromosome protein, H6, which has very 
powerful activity against a range of bacteria (MICs 0.06–0.12 μM) [112]. This fragment, designated as 
oncorhyncin III, is salt sensitive, non-haemolytic and able to destabilize planar lipid membranes [112]. 
Another intracellular protein found to have antibacterial effects is a 6.6 kDa fragment derived from the 
40S ribosomal protein, called S30 [113] (Table 3) from skin secretions of O. mykiss. S30 inhibits the 
growth of Gram-positive and Gram-negative bacteria but has strongest microbicidal activity against 
the Gram-positive species [113]. Three ribosomal-derived proteins and peptides, namely L40, L36A 
and L35, (6.4, 12.3 and 14. 2 kDa, respectively), have also been isolated from the epidermal mucus of 
Atlantic cod, Gadus morhua [111] (Table 3). The remarkably strong activity of core and linker 
histones, as well as ribosome-derived proteins, raises questions about the contribution of their   
anti-infective properties to defence, as they would normally not be exposed to invasive bacteria, even 
intracellular ones. Mar. Drugs 2010, 8        
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Table 3. Unconventional antimicrobial proteins and peptides derived from intracellular structures of fish and invertebrates. 
Protein/peptide  Location  Active factor  Reported activity 
1 Source Key  reference 
Histone H1  Nucleus 
Whole protein (20.7 kDa) 
N-terminus (26 aa) (HSDF-1) 
C-terminus (69 aa) (oncorhyncin II)  
Fragment (not specified) 
G– 
G– 
G+, G–  
G+ 
Salmon 
Salmon 
Rainbow trout 
Shrimp 
Richards et al. [104] 
Patrzykat et al. [103] 
Fernandes et al. [107] 
Patat et al. [108] 
Histone H2A  Nucleus 
Whole protein (13.5 kDa) 
Whole protein (13.5 kDa) 
Whole protein (13.5 kDa) 
N-terminus (51 aa) (hipposin) 
N-terminus (19 aa) (parasin-1) 
N-terminus (40 aa) (abhisin) 
G+, F 
G+, H 
G+, G– 
G+, G– 
G+, G–, F  
G+, F, Cy 
Channel catfish 
Rainbow trout 
Shrimp  
Halibut 
Catfish 
Abalone 
Robinette et al. [102] 
Fernandes et al. [105] 
Patat et al. [108] 
Birkemo et al. [109]  
Park et al. [101] 
De Zoysa et al. [110] 
Histone H2B  Nucleus 
Whole protein (13.8 kDa)  
Whole protein (15.5 kDa) 
Whole protein (13.5 kDa) 
G– 
G–, F 
G+ 
Cod 
Channel catfish 
Shrimp 
Bergsson et al. [111] 
Robinette et al. [102] 
Patat et al. [108] 
Histone H3  Nucleus  Whole protein (15.3 kDa)  G+  Shrimp  Patat et al. [108] 
Histone H4  Nucleus  Whole protein (11.3 kDa)  G+  Shrimp  Patat et al. [108] 
HMG H6  Nucleus  Whole protein (6.7 kDa) (oncorhyncin III)  G+, G–  Fish  Fernandes et al. [112] 
40Rsp30 
60RspL40 
60RspL36A 
60RspL35 
Ribosomes 
Whole protein (6.7 kDa) 
Whole protein (6.4 kDa) 
Whole protein (12.3 kDa) 
Whole protein (14.2 kDa) 
G+ 
G+, G– 
G+ G– 
G+ 
Rainbow trout 
Cod 
Cod 
Cod 
Fernandes and Smith [113]  
Bergsson et al. [111] 
Bergsson et al. [111] 
Bergsson et al. [111] 
1 G+, Gram-positive; G–, Gram-negative; F, Fungi; H, haemolytic; Cy, cytotoxic. Mar. Drugs 2010, 8        
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3.2. Membrane-derived antimicrobial compounds 
3.2.1. Free fatty acids  
The cell membranes of eukaryotic organisms can also be an important source of several 
antimicrobial compounds, with free fatty acids (FFAs) particularly prominent. Fatty acids, especially 
unsaturated varieties, are rarely found in their free form inside living cells [126,127] but more usually 
they are bound to other groups, such as phosphates, sugars or glycerol, forming lipids. Phospholipids are 
the major structural components of cell membranes, while galactolipids are located in the chloroplasts 
and triglyercides may form cellular energy reserves as lipid stores. Fatty acids can be released from cell 
membranes as FFAs upon cell or tissue damage caused typically by a consumer or a pathogen [126–130]. 
There are numerous FFAs with antimicrobial effects and their spectra of action and potencies are 
influenced by the degree of saturation, length of carbon chain and the orientation of the double   
bonds [131] (Table 4). Briefly, amongst the saturated FFAs, capric acid (C10:0) and lauric acid 
(C12:0) tend to be the most active [132–134], while amongst the monounsaturated FFAs, myristoleic 
(C14:1) and palmitoleic acid (C16:1) often are the most potent [132,133] (Table 4). Monounsaturated 
FFAs with less than 14 or more than 16 carbon atoms in the carbon chain tend to have rather less  
activity [132,133] (Table 4). Many polyunsaturated FFAs are potently antibacterial, particularly those 
with 18 and 20 carbons in their carbon chain [132]. Interestingly, a direct relationship can exist 
between the number of double bonds in the carbon chain and the antibacterial activity of the   
FFA [132,135,136] (Table 4). In general FFAs with cis-orientated carbon-carbon double bonds have greater 
antimicrobial activities compared with those FFAs containing trans-orientated bonds [132,137] (Table 4). 
Table 4. Effect of structure on the antibacterial activity of free fatty acids. Antibacterial 
activity was assessed by disc diffusion against the Gram-positive bacterium Bacillus larvae 
with 250 µg of compound per sterile paper disc. The area of microbial growth inhibition 
(clear zone area) was calculated as total area of clear zone minus the area of the disc. Larger 
clear zones indicate greater antibacterial activity. Data modified from Feldlaufer et al. [132]. 
Structural feature  Fatty acid  Clear zone area (mm
2) 
Carbon chain length: saturated 
fatty acids 
C6:0 
C8:0 
C9:0 
C10:0 
C11:0 
C12:0 
C13:0 
C14:0 
C15:0 
C16:0 
C17:0 
C18:0 
0 
223 
1230 
2260 
2800 
5000 
1230 
46.9 
0 
0 
0 
0 Mar. Drugs 2010, 8        
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Table 4. Cont. 
Carbon chain length: 
monounsaturated fatty acids 
C14:1 n-5 
C16:1 n-7 
C18:1 n-9 
C20:1 n-9t 
C22:1 n-9 
5000 
4040 
0 
584 
0 
Degree of unsaturation 
C22:1 n-9 
C22:2 n-6 
C22:3 n-3 
C22:4 n-6 
C22:6 n-3  
0 
584 
1230 
1930 
2090 
Bond orientation(s) 
C16:1 n-7 
C16:1 n-7t 
C18:2 n-9 
C18:2 n-9t
1 
4040 
675 
3600 
1230 
1 Both bonds in trans orientation. 
The microbicidal activities of membrane-derived FFAs have been extensively studied and these 
seem to be important defence effectors, especially in the macro- and micro-algae [126,128–131]. 
Micro-algae, even those species with partial or complete cell armouring, such as diatoms, can lose 
structural integrity through mechanical damage by consumers, osmotic shock, water turbulence and 
viral- or bacterial-induced lysis. Such damage may result in the release of high concentrations of 
FFAs, particularly from the phospholipids of the cell membrane and the galactolipids of the 
chloroplasts, into the vicinity of the damaged cell [127,138,139]. The liberation of FFAs is immediate 
and is carried out by a family of hydrolytic enzymes called lipases [127,140]. During pathogen-
induced lysis the bioactive FFAs are thus brought into close contact with any adjacent prokaryotes, 
whether they are the same pathogen that may have initiated the damage in the first instance, or are 
other heterotrophic opportunists. Killing of these microbes by the released FFA will not, of course, 
save the damaged micro-alga but could help protect its neighbours and would be beneficial, in 
evolutionary terms, to the population if these surrounding cells are clonal or close genetic relatives. In 
this way, pathogen transmission within a micro-algal population can be brought under some control. 
The production of FFAs is a multi-faceted defence strategy in the micro-algae, as these compounds 
are toxic to many threats to host survival, including viruses, protozoans and consumers [126,141]. 
Further, this defence strategy can be considered metabolically inexpensive, as the FFAs come from 
vital structures within the cell and the lipases involved may pre-exist to serve alternative essential 
functions in living cells [142,143]. While micro-alga-pathogen interactions are not well characterised 
there is a growing literature in this field [144–147] but future experimentation must confirm the 
precise role for FFAs against recognised micro-algal pathogens. Pathogen-damaged tissues of   
macro-algae produce FFAs in a similar manner to the micro-algae and these not only kill the pathogen 
and prevent its spread through the host but the FFAs can also act as signals (or precursors of signalling 
molecules) that trigger downstream systemic defence responses [128–130]. 
The marine diatom Phaeodactylum tricornutum is a popular model for investigations of micro-algal 
physiology and it is a good example of a micro-alga that forms antibacterial FFAs through lipase Mar. Drugs 2010, 8        
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action after mechanical disruption of the cells [148]. The main ones are medium- and long-chain 
unsaturated varieties, particularly eicosapaentaenoic acid (C20:5 n-3) [149], hexadecatrienoic acid 
(C16:3 n-4) and palmitoleic acid (C16:1 n-7) [150]. These unsaturated FFAs are typical of those 
isolated from extracts in similar antibacterial bioassay-guided fractionation studies of other macro- and 
micro-algal species [151,152]. Eicosapaentaenoic acid (EPA) has strong activity against a wide range 
of Gram-positive and Gram-negative marine and non-marine bacteria in vitro, including Pseudomonas 
aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA) [149] (Table 5). 
Table 5. Susceptibility of marine bacteria and potential human or animal pathogens to the 
antibacterial effect of eicosapentaenoic acid (EPA) or decadienal (DD). Antibacterial 
activity was assessed by disc diffusion [149] with 1 µM of compound per sterile paper 
disc. The area of microbial growth inhibition was calculated as defined in the legend for 
Table 4. 
Species, strain and Gram’s stain 
1 
Clear zone area (mm
2) 
DD EPA 
Marine isolates    
Aeromonas hydrophila NCIMB 1108 (G–) 483  0.0 
Alteromonas haloplanktis NCIMB 19 (G–)  22.0  0.0 
Listonella anguillarum MT 1637 (G–)  566  15.9 
Photobacterium phosphoreum NCIMB 64 (G–)  22.0  22.0 
Psychrobacter immobilis NCIMB 308 (G–)  84.8 0.0 
Micrococcus luteus NCIMB 9278 (G+)  42.6  50.3 
Planococcus citreus NCIMB 1493 (G+)  1600  50.3 
Opportunistic human and animal pathogens    
Escherichia coli B (G–)  18.9  0.0 
Pseudomonas aeroginosa NCIMB 10775 (G–)  10.2  0.0 
Staphylococcus aureus SH 1000 (G+)  50.3 173 
Staphylococcus epidermidis ATCC 10145 (G+)  22.0  105 
1 G+, Gram-positive; G–, Gram-negative. 
 
Fish and shellfish pathogens, such as Lactococcus garviae, harmful Vibrios and L. anguillarum are 
also killed by EPA although it does not appear to affect fungi [149,153] (Table 5). Similarly, 
hexadecatrienoic acid (HTA) isolated from P. tricornutum displays activity against the Gram-positive 
pathogen, S. aureus [150]. Palmitoleic acid (PA) is active against various non-marine Gram-positive 
human pathogens at micromolar concentrations and begins to kill bacteria upon immediate   
exposure [150]. Like EPA, HTA appears to have little or no activity against fungi [150], although there 
are reports of antifungal activity attributable to PA [154]. Interestingly, higher levels of these and other 
bioactive FFAs are present in the fusiform morphotype of P. tricornutum (the morphotype that tends to 
dominate in the plankton) compared with the oval morphs of this micro-alga, which tend to occur on 
surfaces [155]. It is likely that this is a functional adaptation to prevailing conditions but shows that 
yields of antibacterial FFAs, both naturally in the sea and experimentally in the laboratory, can be 
influenced by growth and environmental conditions. MICs for FFAs against susceptible bacteria are Mar. Drugs 2010, 8        
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typically 100 µM and greater [133,156–158] but, in certain cases, they can be as much as one order of 
magnitude more potent [133,135,159]. However, whilst FFAs may not be as potent as AMPs by direct 
comparison, their fast accumulation and thus potentially greater local concentrations mean that they 
can attain the necessary concentrations to exert their antimicrobial activities. 
FFAs can be bactericidal (kill ≥99.9% of original inoculum) or can reversibly inhibit bacterial 
growth without complete killing (bacteriostatis) [160], although the mechanisms by which they act 
have yet to be fully characterised. There are several ways that they are thought to attack bacterial cells 
but, of these, the cell membrane is probably the prime target [131]. Likely cell processes targeted by 
FFAs include interference with cellular energy production by disrupting the electron transport chain 
and oxidative phosphorylation, inhibition of enzyme activity, impairment of nutrient uptake, 
generation of toxic peroxidation and auto-oxidation degradation products or direct membrane 
disruption causing bacterial cell lysis [131,161]. The exact process responsible is likely to depend on 
the bacterial strain, the FFA concerned and its concentration. It is also probable that FFAs work 
simultaneously on multiple targets within the bacterial cell, thus reducing the likelihood of inducible 
bacterial resistance.  
3.2.2. Oxylipins 
In many species of macro- and micro-algae, the FFAs released by lipases from the phospholipids and 
galactolipids of damaged cells are very rapidly transformed into other compounds 
[127,130,138,139,162]. The usual process is for the FFA to be oxygenated initially by lipoxygenase 
enzymes to give intermediary hydroperoxides [163,164]. Further enzymes convert the hydroperoxides 
into oxylipins, of which there is a great variety, including unsaturated aldehydes and hydroxyl-, keto- 
and epoxyhydroxy fatty acid derivatives [165–168]. The exact repertoire of FFA-derived oxylipins 
depends on the algal species (and sometimes the strain) and the particular suite of enzymes that they 
express [169]. 
Importantly, the oxylipins produced may have appreciably more or, in some cases, less antibacterial 
activity than the FFA from which it was derived [136,170]. Amongst the micro-algal-derived 
oxylipins, it is the antibacterial activities of the polyunsaturated aldehydes (PUAs) that have attracted 
most recent attention. These PUAs are generated by diatoms including Skeletonema costatum and 
Thalassiosira rotula [169]. Diatom-derived PUAs are produced from C16, C20 and C22 
polyunsaturated FFAs, particularly HTA, hexadecatetraenoic acid (C16:4 n-1) and EPA [138,139,162–
164]. These FFAs are first oxygenated by a lipoxygenase and then hydroperoxide lyases act on the 
hydroperoxide intermediates to give PUAs, including heptadienal (C7:2 n-3), octadienal (C8:2 n-4), 
octatrienal (C8:3 n-1) and decadienal (C10:2 n-3) [138,139,162–164]. One typical, well-studied and 
highly antibacterial PUA is decadienal (DD), which is probably derived from the polyunsaturated fatty 
acid, arachidonic acid (C20:4 n-3) [127,141]. DD exhibits strong activity against important Gram-
positive and Gram-negative human pathogens, such as MRSA and Haemophilus influenzae with MIC 
values of 7.8 and 1.9 μg mL
−1, respectively [171]. DD at micromolar concentrations also detrimentally 
affects the growth of diverse Gram-positive and Gram-negative marine bacteria [172,173] (Table 5). 
Indeed, DD is also highly antagonistic towards numerous non-marine bacterial species (Table 5) and 
there is also evidence for activity against fungi [172]. Little work has been performed to characterise Mar. Drugs 2010, 8        
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the antibacterial activities of PUAs and further studies in this field are warranted. Importantly, it is 
necessary to discriminate between bactericidal and bacteristatic activities. Such studies would begin to 
elucidate their specific mechanism(s) of antibacterial action.  
3.3. Pigment or pigment-derived antimicrobials  
Many marine or aquatic organisms synthesize pigments for a variety of purposes, including 
camouflage or warning colouration, oxygen transport, signalling, or protection against ultraviolet 
radiation, predation and microbial colonization. Some of these pigments serve multiple functions. 
Blood borne pigments are especially well placed to contribute to antibiosis as they permeate all tissues 
and organs. It is therefore not surprising that a number of respiratory or other blood pigments either 
have direct antimicrobial properties or contain motifs that upon liberation by degradative enzymes are 
microbicidal (Table 6). 
3.3.1. Respiratory pigments 
The antimicrobial properties of mammalian haemoglobin have been known for a long time [206] 
and the activities are now attributed to peptides derived from the α- and β-subunits within the 
haemoglobin tetramer [207,208]. With fish, Fernandes and Smith [174] have reported the partial 
purification by RP-HPLC of two cationic proteinaceous factors from the acid soluble erythrocyte extracts 
of O. mykiss (Table 6). One of these factors is active against Gram-positive and Gram-negative bacteria 
with MIC values of 7–14 μg mL
−1 and 14–28 μg mL
−1, respectively, while the other is active against 
the Gram-positive bacterium, Planococcus citreus, with a MIC of 1–2 μg mL
−1 [174] (Table 6). All of 
these values are within the sub-micromolar range and are approximately in the same order of 
magnitude as cecropin P1 but, as yet, the exact nature of these proteins is unknown [174]. These 
antimicrobial compounds could be haemoglobin-derived peptides but, as fish have nucleated 
erythrocytes, it is also possible that one or more of the activities might be due to histones or other 
intracellular structures, such as those described above. Other studies have established that two peptides 
derived from the β-subunit of catfish (Ictalurus punctata) haemoglobin have antibacterial activity 
against Gram-negative bacteria and these peptides can also kill Ichthyophthirius multifiliis, a ciliate 
parasite of this fish [209] (Table 6). As the transcript for at least one of these β-subunit-derived 
antimicrobial peptides from haemoglobin seems to be up-regulated in the skin and gill epithelium of  
I. punctata following I. multifiliis infection, it likely that these peptides might act in an anti-infective 
manner for the host [209]. 
Haemocyanin is another important oxygen carrying pigment in the blood of many invertebrates, 
especially large active ones, such as decapod crustaceans. Several studies have revealed its 
involvement in an anti-infective capacity (Table 6). With shrimp, intact haemocyanin can not only 
directly agglutinate bacterial cells [210] thereby restricting their ability to divide and spread around the 
body, but it also has antiviral effects [211]. Mar. Drugs 2010, 8        
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Table 6. Examples of other anti-infective compounds or fragments derived from these compounds, which serve alternative functions in 
marine organisms. 
Name Main  function  Size  Activities 
1  Organism(s) Key  references 
Respiratory pigments 
Haemoglobin fragments 
Haemocyanin fragments 
 
Respiratory pigment 
Respiratory pigment 
 
28, 41 kDa 
7.9, 8.3 kDa 
 
G+, G– 
F 
 
Rainbow trout 
Shrimp 
 
Fernandes and Smith [174] 
Destoumieux et al. [175] 
Other pigments 
Echinochrome A 
Melanin 
 
 
Melanin 
Prophenoloxidase 
Prophenoloxidase 
Aplysianins 
Dolabellin 
L-amino acid oxidases 
Sebastes schlegeli 
antibacterial protein (L-
amino acid oxidase) 
Chlorophyll derivatives 
 
Blood pigment 
Blood pigment 
 
 
Ink pigment 
Enzyme 
Enzyme 
Ink component 
Ink component 
Ink component 
Skin mucus 
 
 
Photosynthetic pigment 
 
266 Da 
∼318 kDa 
 
 
∼318 kDa 
60–77 kDa 
60–77 kDa 
60–320 kDa 
60 kDa 
340 kDa 
120 kDa 
 
 
∼0.6 kDa 
 
G+, G– 
G+, G–, F 
 
 
G+, G–, F 
F 
G+, G– 
G+, G–, F, Cy 
G+, G–, Cy 
G+, G– 
G– 
 
 
G+, G– 
 
Sea urchins 
Crustaceans 
 
 
Octopus 
Solitary ascidian 
Amphioxus 
Sea hares 
Sea hares 
Many organisms 
Fish 
 
 
Various micro-algae 
 
Service and Wardlaw [176] 
Söderhäll and Ajaxon [177]; Nappi 
and Ottaviani [178]; Lin and Chen 
[179]; Burkhart and Burkhart [180] 
Prota et al. [181] 
Hata et al. [182] 
Li et al. [183] 
Yamazaki et al. [184] 
Yamazaki et al. [185] 
Derby [186] 
Kitani et al. [187] 
 
 
Jorgensen [188]; Hansen [189]; 
Bruce et al. [190] 
Pore-forming toxins 
Pardaxin 
Actinoporins 
Sticholysins 
Grammistins 
 
Skin toxin 
Skin toxin 
Skin toxin 
Skin toxin 
 
3–4 kDa 
20 kDa 
20 kDa 
∼1–3 kDa 
 
G+, G–, H 
H, Cy 
H, Cy 
G+, G– 
 
Flatfish 
Sea anemones 
Sea anemones 
Soapfish 
 
Lazarovici et al. [48] 
Kristan et al. [191] 
Alvarez et al. [192] 
Yokota et al. [193];  
Sugiyama et al. [194] 
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Table 6. Cont. 
Name Main  function  Size  Activities 
1  Organism(s) Key  references 
Neuropeptides 
Peptide B 
 
Neuropeptide fragment 
 
2.5–3.5 kDa 
 
G+ 
 
Mussel 
 
Tasiemski et al. [195] 
Regulatory factors 
HDL/ApoA-1 
HDL/ApoA-1 
 
Various functions 
Various functions 
 
29.5 kDa 
29.5 kDa 
 
G+, G– 
G+, G– 
 
Carp 
Rainbow trout 
 
Concha et al. [196] 
Villaroel et al. [197] 
Lectins 
ESA 
GMA 
LEC_SUBDO 
CvL 
Sialic-acid binding lectin 
Scyllin 
Tachylectin-1 
HSL 
 
Lectin 
Lectin 
Lectin 
Lectin 
Lectin 
Lectin 
Lectin 
Lectin 
 
Not specified 
Not specified 
27 kDa 
106 kDa 
∼51 kDa 
5 kDa 
27 kDa 
182 kDa 
 
G– 
G– 
G+, G– 
G+ 
G– 
G+, G– 
G– 
G+, G– 
 
Red alga 
Red alga 
Sponge 
Sponge 
Bivalve mollusc 
Mud crab 
Horseshoe crabs 
Holothurian 
 
Liao et al. [198] 
Liao et al. [198] 
Schroeder et al. [199] 
Moura et al. [200] 
Tunkijjanukij and Olafsen [201] 
Chattopadhyay and Chatterjee [202] 
Saito et al. [203] 
Gowda et al. [204] 
Binding molecules 
Anti-lipopolysaccharide 
factor (ALF) 
 
Endotoxin-binding protein 
 
∼15 kDa 
 
G– 
 
Horseshoe crabs 
 
Morita et al. [205] 
1 G+, Gram-positive; G–, Gram-negative; F, Fungi; H, haemolytic; Cy, cytotoxic.Mar. Drugs 2010, 8        
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Perhaps more interestingly, two antifungal peptides of 2.7 and 7.0–8.3 kDa, respectively are 
generated by limited proteolytic cleavage at the C-terminus of haemocyanin from the shrimp, 
Litopenaeus vannamei [175]. These peptides have strong activities against a range of fungi with MIC 
values of ∼3–12 µM [175] (Table 6). They probably serve to kill fungi that may penetrate into the 
haemocoel through the carapace but their effects do not appear to be due to heavy metal or binding sites 
for bivalent ions [175]. In addition to these, another antibacterial peptide, astacidin-1, appears to be 
generated from the C-terminus of haemocyanin from the crayfish, Pacifastacus leniusculus, by 
proteolytic cleavage in acidic conditions [212]. This peptide is active against a range of Gram-positive and 
Gram-negative bacteria, including some human pathogens, at MIC values ranging from 2–20 μM [212]. 
The bioactivity of astacidin-1, which contains a β-sheet like many conventional AMPs, seems to reside 
at its N-terminus and its importance in host defence is demonstrated by its increased release into the 
haemolymph after crayfish have received injections of bacterial LPS [212]. 
3.3.2. Other pigments 
An example of a non-respiratory blood pigment that has antimicrobial effects is echinochrome A 
from echinoderms, particularly sea urchins (Table 6). Echinochrome is an orange-red coloured 
naphthoquinone (6-ethyl-2,3,5,7,8-pentahydroxy-1,4-naphthoquinone) that has iron chelating and free 
radical scavenging properties [213]. Echinochrome A is abundant in the red spherule coelomocytes of 
echinoid coelomic fluid [214]. It was found to have bactericidal properties by Service and   
Wardlaw [176] working with the common European sea urchin, Echinus esculentus. In this species it 
is present in the cells at 3–60 μg mL
−1 and, importantly, it is active against a range of Gram-positive 
and Gram-negative bacteria at 50 μg mL
−1 [176] (Table 6). It is highly likely to owe its antibacterial 
effects to iron-chelation and, as it is also present in urchin eggs and larvae, it may assist in preventing 
microbial colonization after spawning and fertilization.  
Melanin is a pigment that occurs in many organisms: animals, plants, fungi and bacteria. Indeed, for 
many marine protostome invertebrates, particularly crustaceans and molluscs, and to a lesser extent, in 
annelids and ascidians, melanisation is a conspicuous immune response to infection. In these animals, 
wounds and abrasions to the external body surface rapidly become melanised, while internally melanin 
deposition accompanies the formation of haemocyte capsules around fungi, parasites or bacteria that 
have gained access to the haemocoel or coelomic cavity. The occurrence of melanin at sites of injury 
or infection in so many taxa has led to the general conception that melanin, and/or its quinone 
precursors, have anti-infective properties (Table 6) and a number of papers have appeared offering 
experimental data to support this [177–180]. However, it has also been argued that melanin is not a 
significant anti-infective, particularly as some fungi and pathogenic bacteria defend themselves against 
attack by the host immune system by utilizing melanin, either synthesized by themselves or produced 
by the host [215]. Certainly melanin has anti-oxidant properties, particularly through mopping up 
H2O2, so it may be exploited by some pathogens for protection against the effects of reactive   
oxygen intermediates generated by the host phagocytes. However other invaders, such as fungal 
hyphae, are essentially sequestered by this insoluble polymer into the haemocyte capsule matrix and 
then asphyxiated. Mar. Drugs 2010, 8        
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What may be important in relation to any anti-septic benefits of melanisation, at least in some 
protostome invertebrates, is the enzymatic oxidation of phenolic molecules to form the quinone 
precursors of melanin. The enzyme responsible is phenoloxidase (PO) and the activation of PO from 
its inactive precursor, proPO, is known to be a key defence response to microbial infection in many 
marine and non-marine invertebrates. Certainly, purified phenoloxidase from blood cells of the solitary 
ascidian, Halocynthia roretzi, has antibacterial activity in the presence of -(3,4-dihydroxy)-phenylalanine 
(L-dopa) [182] and indirect evidence has been provided that PO from the cephalochordate, Amphioxus 
belcheri, has antibacterial effects [183] (Table 6). In arthropods, phenoloxidase-catalyzed reactions 
have been found to produce antimicrobial reactive intermediates from natural substrates [216] and in 
shrimp silencing of the gene encoding prophenoloxidase by RNA interference results in a significant 
increase in bacterial load in the haemolymph [217]. Importantly, too, work on crustaceans has shown 
that proteolytic cleavage of haemocyanin, not only generates an antibacterial peptide from the   
C-terminus [212] but also produces PO from the N-terminus of subunit 2 [218]. Thus there is a clear 
link between haemocyanin, melanization reactions and microbial killing in invertebrates. 
Not all pigments that show anti-infective effects are present in blood or body fluids circulating 
freely through the body. Indeed, the ink produced by some cepalopods and opistobranch gastropods 
upon attack or threat as defensive, anti-predator shields has been found to possess a number of factors 
with antibacterial, antifungal and/or cytotoxic activities [184,219,220]. At least one such pigment in 
the ink of octopus is melanin [181] but in gastropods, especially those belonging to the genera Aplysia 
and Dolabella, other antimicrobial factors occur (Table 6). One is a 60 kDa glycoprotein, termed 
aplysianin P [184,185]. This is bacteriostatic against various Gram-positive and Gram-negative 
bacteria at 0.2–5.8 μg mL
−1 and seems to function by completely inhibiting the syntheses of bacterial 
DNA and RNA; a property that also lends it cytotoxic activity against eukaryotic tumour cells [184]. 
Related aplysianins are present in the albumin gland (aplysianin A) and eggs (aplysianin E) of   
A. kurodai [221,222]. The latter must certainly help the eggs from being colonized by bacterial and 
fungal epibionts. All of these aplysianins possess L-amino acid oxidase (LAAO) activity placing them 
within the family of LAAO enzymes. As the name suggests these deaminate L-amino acids in an 
oxidative manner to yield various microbicidal molecules, including H2O2, NH
+ ions, carboxyl acids 
and α-keto acids [186,187,223]. A wide variety of LAAOs occur in marine and other organisms and 
most have broad-spectrum anti-infective properties [186]. One, designated Sebastes schlegeli 
antibacterial protein, is present in skin secretions of the rockfish, Sebastes schlegeli, and is active 
against the Gram-negative fish pathogens A. hydrophila, A. salmonicida and Photobacterium damselae 
ssp. piscicida [187] (Table 6). It has a yellow colouration and is derived from a 120 kDa homodimeric 
glycoprotein [187] (Table 6). Different LAAOs have different substrate specificity but the generation 
of the bactericidal products is usually very rapid [224]. One LAAO homolog of the aplysianins in sea 
hare ink is escapin, a 60 kDa monomer that has high oxidase activity with either L-lysine or L-arginine, 
and seems to kill actively growing bacteria by a variety of mechanisms, including hydrogen peroxide 
release [224]. Escapin is a highly stable compound that preferentially kills Gram-negative bacteria at 
MIC of ∼0.25–0.62 μM mL
−1, although it also prevents the growth of some Gram-positives, including 
S. aureus and has mild activity against certain fungi [224].  
With micro-algae, several photosynthetic pigments or derivatives have been isolated and found to 
have microbicidal effects (Table 6). Jorgensen [188] reported the isolation of an antibacterial Mar. Drugs 2010, 8        
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derivative of chlorophyll from extracts prepared from three different micro-algae (Chlamydomonas 
reinhardi, Chlorella vulgaris, Scendesmus quadricauda), which is active against the Gram-positive 
bacterium,  Bacillus subtilis. The same compound, thought to be a photo-oxidation product of the 
chlorophyll derivative chlorophyllide a, was later isolated by Hansen [189] from acetone extracts of 
the chrysophyte, Ochromonas malhamensis. This antibacterial agent is active against Gram-positive 
and Gram-negative bacteria. In the same study, two further pigment derivatives with antibacterial 
activity were isolated but these could not be identified conclusively [189]. Finally, Bruce et al. [190] 
also reported the isolation of two chlorophyll a derivatives, which are active against Gram-positive 
and Gram-negative marine bacteria. 
3.4. Pore-forming toxins 
Many toxins have been identified from marine animals. Some groups of toxins share secondary 
structures with conventional AMP groups, whereas a small number have also been recorded to have 
antimicrobial activities. In addition, it is common for AMPs to gain access to the interior of a cell via 
pore-formation in the cytoplasmic membrane, which is a strategy employed by certain toxins. The 
best-known examples of these are the pardaxins of fish (Section 2.1.2) that were originally purified on 
the basis of their toxic, anti-predatory activity [48] yet have similar antibacterial potencies to the 
amphibian magainins and insect cecropins [50] 
Secondary structures widespread in AMPS are also found in actinoporins, which are pore-forming 
toxins from the sea anemone, Actinia equina [191]. In particular, similarities exist between the 
actinoporin, equinotoxin II, and a major component of bee venom, melittin, that has strong 
antibacterial activity [225]. Similar to conventional AMPs, actinoporins contain an amphipathic region 
and a hydrophobic β-sandwich core (i.e., a twisted β-sheet structure) with two adjacent α-helices 
[225]. The actinoporins appear to attach to membranes via the β-sandwich core while their actual  
pore-forming abilities appear to be mediated through the insertion of α-helices into membranes to form 
ion channels [226]. A recent review of membrane damage by proteins and toxins, including 
actinoporins, is given in Anderluh and Lakey [226]. Secondary structure similarities also exist between 
the tachystatins of horseshoe crabs and ω-agatoxins [66] of spiders (as discussed in Section 2.2.1). 
Other examples of pore-forming, α-helical toxins include the sticholysins from the sea anemone, 
Stichodactyla helianthus [192] and grammistins from the soapfishes, Pogonoperca punctata and 
Grammistes sexlineatus [193,194] (Table 6). The grammistins are active against Gram-positive (MIC 
3.13 µg mL
−1) and Gram-negative (MIC 6.25 µg mL
−1) bacteria [194]. Although common structures 
are shared between AMPs and pore-forming toxins there are few reports concerning antimicrobial 
activities of the latter and this is an area worthy of further investigation.  
3.5. Neuropeptides 
Neuropeptides share several properties with AMPs, including amphipathicity, cationic charge and 
size. In addition, several neuropeptides (enkelytin, peptide B) and peptide hormones (e.g., neurotensin, 
bradykinin) from mammals have antimicrobial properties [227]. The antimicrobial activities of 
neuropeptides have not been widely investigated in fish or invertebrates [228], however there is evidence 
that neuropeptide fragments from the mussel, M. edulis, and the leech, Theromyzon tessulatum, possess Mar. Drugs 2010, 8        
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antibacterial activities [195]. The opioid precursor pro-enkephalin A (PEA) releases smaller peptides 
when either animal species is challenged by LPS or physically stressed, e.g., via small surgical   
cuts [195]. The purified fragment, peptide B, from M. edulis is antimicrobial against Gram-positive 
bacteria [195] (Table 6). 
3.6. Regulatory binding and other molecules 
In addition to the unconventional anti-infectives derived from intracellular structures and pigments 
are a number of molecules that do not seem to be dedicated or professional AMPs, as they are often 
better known for functions other than defence. One is high-density lipoprotein (HDL), a component of 
mammalian blood serum. HDL has several physiological functions, but it is mainly associated with the 
transport of cholesterol and other lipids from atheroma of arteries to the liver. Along with its 
constituent apolipoproteins (apoAs) it further helps to inhibit damaging oxidative processes, regulate 
inflammation and modulate blood coagulation by affecting platelet aggregation. However, HDL and its 
apoA molecules also have antimicrobial properties [229–231] and appear to be cytotoxic to trypanosome 
parasites [232] (Table 6). The bactericidal activity of these molecules is likely to be due to the 
presence of amphipathic α-helices that enables them to attack the prokaryotic inner leaflet in a similar 
way to conventional α-helical AMPs. In mammals, serum HDL levels are only around 0.4–0.6 mg mL
−1 
and its contribution to non-specific immunity in mammals may be as a platform for the assembly of 
multi-component immune complexes [232]. By contrast, teleost fish have much higher levels of HDL, 
somewhere in the region of ∼9–35 mg mL
−1 [233] so HDL together with its derived apoAs could make 
a significant contribution to defence, especially as fish have greater reliance on innate immunity than 
warm blooded vertebrates. Indeed, HDL and apoAs from carp, trout and sea bass have been shown to 
have antibacterial activity against a range of bacteria [196,197,234,235], with inhibitory 
concentrations in the micromolar range [197]. HDL and its associated apoAs are also detectable and 
active in the skin epithelia of fish [198,234] revealing that they function as microbicidal effectors not 
only systemically but also in the mucosa. 
3.7. Lectins  
Invertebrates generally express different types of defence proteins in the blood plasma, of which 
many are involved in non-self recognition and in host defence. There are two types of molecule within 
the plasma of several protostome invertebrates that are primarily associated with recognition events, 
but that also appear to have antimicrobial effects (Table 6). One group, the lectins, bind sugars and are 
present in a wide variety of species, while the other group, anti-lipopolysaccharide factors (ALFs), are 
mainly found in arthropods, especially decapod crustaceans and horseshoe crabs, and bind LPS from 
Gram-negative bacteria. 
Lectins are glycoproteins that bind specific carbohydrate moieties. A large number of lectins have 
been reported from marine invertebrates, often from immune cells or haemolymph [236]. 
Agglutination of bacteria is normally tested as part of lectin characterization, as agglutination may aid 
bacterial clearance by facilitating phagocytosis. However, parallel tests for direct bactericidal activity 
are frequently omitted from these analyses. A few reports exist of lectins with antimicrobial activity 
from marine macro-algae and invertebrates. Lectins from two red algal species, Eucheuma serra and Mar. Drugs 2010, 8        
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Galaxaura marginata, inhibit the growth of Vibrio vulnificus and V. pelagicus although the inhibition 
was not recorded for all the Vibrio species tested and no Gram-positive bacteria were included in the 
screening [199] (Table 6).  
Of marine invertebrate groups, antibacterial activity has been recorded for lectins from the sponges 
Suberites domuncula [200] and Cliona varians [201], the bivalve Modiolus modiolus [202], the crab, 
Scylla serrata [203], the horseshoe crab T. tridentatus [20] and the echinoderm Holothuria scabra [205] 
(Table 6). The S. domuncula lectin (designated LEC_SUBDO) was cloned from cultured S. domuncula 
cells using primers designed from two conserved regions of a galactose-binding protein from   
T. tridentatus and the native lectin was also purified from sponge cells [200]. Whereas native and 
recombinant LEC_SUBDO inhibit growth of E. coli by 81% and 36%, respectively, at a concentration of 
300 µg mL
−1, inhibition against the Gram-positive species S. aureus is much less (<15% inhibition) 
[200]. CvL, a lectin purified from the sponge, C. varians, is active against Gram-positive bacteria, 
inhibiting growth by 90% at 100 µg mL
−1 [201]. Regarding bivalves, a sialic-acid binding lectin has 
been purified from the horse-mussel, Modiolus modiolus, which is particularly active against Vibrio  
species [202]. From crustaceans, a 5 kDa bactericidal lectin called scyllin has been purified from  
S. serrata [203]. Amongst the large group of horseshoe crab lectins, tachylectin 1 (originally called 
L6) from T. tridentatus, agglutinates both Gram-positive and Gram-negative bacteria but only inhibits 
the growth of Gram-negative species [204]. A recent study has purified a lectin (HSL) from the 
holothurian echinoderm, Holothuria scabra, which has activities against Gram-positive and   
Gram-negative bacteria [205] (Table 6). 
The antimicrobial activities of fish lectins are less well established. Whilst some appear to inhibit 
bacteria this is not necessarily due to direct killing. An example is galectin from the eel,   
Anguilla japonica, that inhibits biofilm formation by human periodontopathic bacteria yet is not 
bactericidal [237]. A fish lectin that does have antibacterial activity, but only against E. coli when 
tested against a range of Gram-positive and Gram-negative bacteria, has been isolated from the ovary 
of the cobia, Rachycentron canadum [238].  
3.8. Binding molecules 
Anti-lipopolysaccharide factors (ALFs) are LPS-binding proteins that were discovered through   
their ability to inhibit LPS-induced clotting in the horseshoe crabs, Tachypleus tridentatus and   
Limulus polyphemus [239]. They are small basic peptides of ∼100 amino acids that have strong affinity 
for negatively-charged surfaces, a feature that contributes to their LPS-binding and anti-coagulation 
properties [206]. High-resolution crystal analyses reveal that these molecules have a single domain of 
three α-helices packed against a four-stranded β-sheet, giving them a wedge-shaped appearance [240]. 
The molecules have a charge distribution that gives them striking amphipathicity and they interact 
with LPS by virtue of an amphipathic disulphide loop at its N-terminus [240–242].  
However, in addition to their LPS-binding properties, ALFs also have strong microbicidal 
activities, mainly against Gram-negative bacteria [206] (Table 6). They are contained within the large 
granules of amoebocytes [64], unlike the more conventional antimicrobial peptides, e.g., tachyplesins, 
which are expressed in the small granules [243]. So they not only constitute a separate category of 
microbicidal proteins but are also segregated from them within the circulating blood cells. ALF Mar. Drugs 2010, 8        
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molecules or genes have also been identified in shrimps [244–246], lobsters [247] and decapod crabs 
[19,248]. In all these species they are expressed and stored in the granules of circulating haemocytes 
and are rapidly released from the granules after exposure to bacterial LPS.  
ALFs are one of a number of factors within the horseshoe crab clotting system that are extensively 
studied for their biopharmaceutical value. So far interest has lain mainly in their value as endotoxin-
neutralising agents to prevent or mitigate septic shock in patients with serious bacteraemia but they 
also appear to have other pharmacological effects on mammalian immune cells, including modulation 
of cytokine expression [249,250]. Examples of the effects of this molecule include inhibition of TNFα 
production from mammalian leucocytes, inhibition of nitrate formation by LPS-activated murine 
macrophages and activation of human mononuclear cells to release antiviral proteins (mainly 
interferons) [249,250]. These properties, combined with their microbicidal effects on certain human 
pathogens, illustrate well the potential value of novel compounds from marine invertebrates.  
4. Discussion  
As is evident from this brief survey of anti-infective agents from marine or aquatic fish, 
invertebrates and micro-algae, these eukaryotic organisms express a very wide range of compounds 
including not only conventional, (i.e., ‘dedicated’) antimicrobial peptides within the immune system 
but also a large array of proteins, protein fragments, lipoproteins, glycoproteins or other factors that 
have, or are derived from, compounds with other primary biological functions. The sheer number of 
different types expressed even within a single species is quite remarkable, and could not have been 
imagined thirty or forty years ago, before the discovery of AMPs stimulated prospecting for novel 
antibiotics from natural sources. Why do so many molecules have, or appear to have, antibiotic 
effects? Do they all have, or have had at some point in evolution, some survival benefits against micro-
organisms for the host? Are they also of potential value to us as novel anti-infective drugs or 
treatments? Importantly, too, are there other compounds, not currently considered as direct innate 
immune effectors, made by marine or aquatic organisms that possess antimicrobial properties and 
could show promise for future medical or commercial exploitation? 
4.1. Diversity and evolution of antibacterial molecules 
It is possible only to speculate as to why so many different molecules in eukaryotic organisms have 
the ability to kill micro-organisms. Obviously the threat to eukaryotes from prokaryotic competitors is 
very great, especially in the sea where microbes abound and nutrients are generally low. Even the 
earliest eukaryotes in evolution would have needed to protect themselves from prokaryotic 
domination. Small peptides are generally considered to be the most ancient of microbicidal agents 
because they are so ubiquitous and their simple molecular configuration makes them inexpensive to 
produce, even by organisms without specialized tissues and defence cells. It is plausible that certain 
functional molecular motifs, such as amphipathic α-helices and β-sheets, would have featured 
predominantly in the arsenal employed by our distant eukaryotic ancestors. Over time, these would 
have diversified through mutation and selection pressure from bacterial resistance to produce the great 
variety of AMPs and other molecules that exist today across so many different molecules in widely 
divergent taxa.  Mar. Drugs 2010, 8        
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Certainly, it is curious that many of the unconventional antimicrobial agents described above 
possess amphipathic structures, typically α-helices or β-sheets, even though they are expressed at sites 
that would not necessarily bring them into close contact with invading micro-organisms. A 
breakthrough discovery in 2004 by Brinkmann et al. [251] changed this by revealing a new cell death 
pathway, distinct from necrosis or apoptosis, which operates in inflammation and provides a 
mechanism by which histones and other intracellular proteins may be presented to bacteria or other 
infective agents. This is a process by which chromatin de-condenses but does not fragment within the 
nucleus, and as the nuclear membrane breaks down, is expelled explosively from the cell to form an 
extracellular net or mesh [251–253]. These nets entrap bacteria preventing their spread and facilitate 
their killing by histones and cationic AMPs that characteristically stud the chromatin meshes [251–253]. 
This new cell death process, now termed ETosis (because it is due to the formation of extracellular 
traps), was observed initially in mammalian neutrophils but has subsequently been reported for 
mammalian mast cells [254] and eosinophils [255] (see also [253]). Circumstantial evidence has also 
been presented that neutrophils from zebrafish and fathead minnow exhibit a similar process 
[256,257], as do phagocytes from insects [258] and marine crabs (Roulston, Robb, Rossi, Dyrynda and 
Smith, unpublished observations), although further work is needed to confirm that these invertebrate 
nets are equivalent to those produced by mammalian neutrophils. It would be interesting to establish if 
ETosis is also performed by the wandering, mesogleal phagocytes of acoelomates or even single-
celled eukaryotes, such as micro-algae. If ETosis is indeed a very ancient process, it would enable us 
to regard histones, ribosomal peptides, membrane-derived free fatty acids or other antimicrobials 
derived from intracellular structures not as ‘unusual’ or ‘unconventional’ effectors but as primordial 
ones for the Eukaryota as a whole. With this information, we would then have a much clearer idea 
whether or not, at some point in evolution, apparently unusual anti-infective molecules had some 
survival benefits against micro-organisms for the host. 
4.2. Potential value of marine eukaryotic anti-infectives 
With respect to the question regarding the potential value of the anti-infective agents already 
described for marine and aquatic organisms in clinical, veterinary or biotechnological application, the 
jury is still out. So far, relatively few have received commercial consideration; the clotting and ALFs 
from horseshoe crabs being the notable exceptions (although it should be noted that these have been 
known and studied for over 20 years). Clearly many new antimicrobial agents are being discovered in 
marine animals and the growing list of such antimicrobial proteins now on databases or described in 
learned journals reflects the huge input of research time and money that are made available for   
bio-prospecting projects. The more we look, the more we find, although at this stage it is hard to know 
which of these novel antimicrobials might endure and become market successes. Many may not pass 
muster because of problems of toxicity, antigenicity and production costs. Others might show initial 
promise but have poor stability within the mammalian body, be unpalatable and therefore of limited 
use in food preservation or they may be ineffective against the most problematic pathogens that affect 
human society. Another problem is whether patent rights would be possible for some ubiquitous   
well-known compounds, such as free fatty acids and histones, even though they may score highly on 
potency, stability and patient toleration. Notwithstanding these issues, the use of histone H1 as a Mar. Drugs 2010, 8        
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synthetic additive to pharamaceutical or nutraceutical formulations or kits has already been   
patented [259]. 
Certainly, the available information for many marine anti-infectives from eukaryotes is patchy. 
Potency measures vary from author to author as do the choice of test micro-organisms and the tissue or 
cells from which extracts are made. Thus it is difficult to make comparisons between compounds at 
least in relation to efficacy. In terms of drug development, what also matters are the assay conditions 
under which antimicrobial activity is measured. The tissues of marine eukaryotes, especially 
invertebrates and micro-algae, are often iso-osmotic to seawater, so any antibacterial compounds they 
synthesise might be expected to function under the high salt and slightly alkaline conditions of their 
environment if they are to serve a useful purpose in defence for their host. However, it is well known 
that many antimicrobials lose their activity under high salt or inappropriate pH conditions, usually as a 
consequence of alterations in charge, folding and amphipathicity of the active molecule [44,260,261]. 
Indeed the effect of salt is a particular issue in the development of new antibiotics for topical 
application (i.e., on the skin) as sweat creates a hyper-osmotic environment. It is therefore important in 
the discovery of new anti-infectives that microbicidal activity is assessed under conditions both 
physiologically relevant to the host from which it was sourced as well as those under which it might be 
deployed in commercial or clinical use. Salt stability is a desirable characteristic to obtain or engineer 
into new drugs although relatively few natural anti-infectives are known to have a high salt 
requirement. One compound that does require high salt concentrations is the 11.5 kDa crustin, 
carcinin, from the shore crab, Carcinus maenas [82]. This protein loses its activity if it is assayed in 
buffers containing 0.7 M NaCl even against a marine bacterium that is normally very susceptible to its 
effects but has been acclimated to low salt conditions by repeat sub-culturing into media of reduced 
salinities [82]. At present the reason for this salt requirement is unknown but for some other anti-
infectives progress has been achieved in modifying the active molecules, for instance by helix capping 
motifs [262] or by inclusion of cyclic tricystine structures [261], to improve their performance in high 
saline conditions. Additional, valuable information about other strategies that could address problems 
such as salt stability might emerge from further analyses of natural peptide antibiotics from   
marine animals. 
4.3. Promise for future medical or commercial exploitation 
For the future, prospecting projects on marine fish, invertebrates and micro-algae might offer 
insights not only into how salt stability of antibiotics may be improved but also in expanding our 
knowledge of the diversity of chemical structures that bring about bacterial killing. The way 
amphipathic structures kill bacteria are well understood [35,36] but alternate processes that work, not 
just at the membrane but within the bacterial cell, are less so. For example, histone H2A-derived 
fragments seem to bind to and interact with bacterial DNA [263]. Such processes need deeper analysis 
and others may be discovered that have completely novel ways of inactivating or killing bacterial cells. 
4.3.1. Synergy 
Importantly, too, little effort has been exerted into exploring the use of anti-infectives from marine 
eukaryotes in combination therapies with traditional antibiotics. Certainly synergy between different Mar. Drugs 2010, 8        
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antimicrobials produced within the same organism must occur in nature, and there are a few sporadic 
reports of synergism occurring between co-expressed proteins in some fish or invertebrates. For 
example, with invertebrates, Gueguen et al. [97] used an in vitro checkerboard assay to study synergy 
between recombinant defensin and synthetic fragments of a 61-residue proline-rich AMP from the 
oyster, C. gigas. The combination of these agents produced around a threefold increase in the killing of 
E. coli [97]. Synergism between tachycitin and big defensin, two conventional antimicrobial peptides 
from amoebocytes of horseshoe crab, Tachypleus tridentatus, has also been reported [264]. As little as 
0.9 µg mL
−1 tachycitin reduces the IC50 of big defensin from 0.8 µg mL
−1 to 0.015 µg mL
−1 [264]. 
Lysozyme is another important anti-infective in a wide range of coelomate animals that can 
synergize with other anti-infectives. It occurs very widely across the animal kingdom, often in multiple 
forms and has the effect of breaking open the peptidoglycan cell wall of Gram-positive bacteria, thus 
allowing AMPs to enter the cell and permeabilize the inner leaflet. Accordingly it can serve both as a 
direct effector and as synergiser of AMP activity. Notably, teleost fish possess multiple types of 
lysozyme-like muramidases, especially in skin secretions. These include not only the conventional 
cationic lysozymes but also an unusual anionic type of muramidase, which has yet to be fully 
characterised [265]. Concha et al. [197] has also reported that lysozyme enhances the antimicrobial 
ability of apoA-1 from carp, and a further example of synergism between different antimicrobial 
proteins is given by the work of Patrzykat et al. [103]. These authors combined native pleurocidin with 
lysozyme, HSDF-1 or HSDF-2 (two different fragments of histone H1 from Coho salmon). These 
combinations produced highly synergistic improvements in inhibiting the growth of the fish pathogens, 
Aeromonas salmonicida and L. anguillarum [103] and shows that histones also have potential to be 
deployed as synergists for other antibiotic substances. Histones are known to disrupt lipid bilayers but 
do not seem to form pores in bacteria and do not have haemolytic effects [105,175] so could be well 
tolerated by patients receiving such treatments.   
Oxylipins and FFAs, too, might find application in combination therapies, as synergists for   
non-lipid anti-infectives, including some of those described above. Unfortunately few studies have 
investigated the potential of oxylipins, despite their known activities against important pathogens 
[172] (Table 5). By contrast FFAs are already on the agenda for exploitation as bio-pharmaceuticals 
alone or in synergy with anti-infectives for use in medicine [159,266,267]. The great advantage of 
FFAs lies in their broad-spectra of activity, high potency, relative safety and the lack of inducible 
resistant phenotypes [134,268–271]. Those from micro-algal extracts should be of high quality, cheap 
and easy to produce on a commercial scale and have already shown particular promise in formulations 
to prevent the colonisation of human skin by opportunistic pathogens, such as MRSA [272]. Fatty  
acid-enriched gels have been produced that may be useful in preventing the spread of sexual 
transmitted bacterial and viral pathogens [273], while the palmitoleic acid isomer, C16:1n-10, has been 
found to be effective at reducing systemic staphylococcal burden in mice and therefore might prove 
valuable for the treatment of serious systemic infections of humans by S. aureus and MRSA [274]. 
4.3.2. Chimeric compounds 
A final word might be said about the possibility of using knowledge obtained about the structures 
and gene organisation of marine-derived anti-infectives to design chimeric compounds that effectively Mar. Drugs 2010, 8        
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combine synergistic or additive motifs into a single molecule or drug. Some recent work on 
conventional AMPs from crustaceans has revealed that nature has already created some multi-domain 
AMPs, each domain of which being known from other research to have independent, potent 
antimicrobial properties. Good examples are afforded by hyastatin from the spider crab,   
Hyas arenaeus [16] and  penaeidins from shrimp [17]. The penaeidin domains comprise a   
proline-arginine-rich region at the N-terminus and a cysteine-rich one at the C-terminus [275] (Figure 1). 
The proline-rich region is unstructured and forms a long tail, in contrast to the highly ordered 
conformation of the C-terminus, which is tightly coiled with an α-helix and three disulphide   
bonds [277]. The chitin-binding activity of the C-terminus is likely to contribute to the antifungal 
properties of the penaeidins, and may also allow the peptide to become anchored to the carapace 
during wound healing or at the moult [276]. The N-terminus proline-arginine-rich domain, however, 
seems to account for the antibacterial properties of the whole molecule [278]. 
The second example from crustaceans, hyastatin, is made up of three domains and, like penaeidins 
and many conventional AMPs, is liberated from its inactive precursor by proteolytic cleavage of the 
N-terminus signal sequence [16] (Figure 1).  
Figure 1. Schematic representation of chimeric domain organisation within penaeidins, 
crustin type II AMPs and hyastatin, three conventional AMPs from crustaceans. WFDC, 
whey four disulphide core containing domain; S-S, signal sequence. The number of 
cysteine residues (C) within the cysteine rich domains is indicated in parentheses. Data 
from Destoumieux et al. [276]; Smith et al. [14] and Sperstad et al. [16]. 
 
The N-terminus of the mature protein has a glycine-rich (LGGG/IGGG) domain and a C-terminus 
cysteine-rich domain with six cysteine residues that probably form an α-helical configuration with 
three disulphide bonds, while in between the termini is a short proline-arginine-rich region [16] 
(Figure 1). The glycine-rich domain has a striking resemblance to the glycine-rich domain of shrimp 
Type II crustins while the C-terminus and central proline-arginine domains are similar to the   
proline-arginine- and cysteine-rich domains of penaeidins [16]. Thus hyastatin appears to be chimeric, 
comprising domains that characterise and account for the functionality of other, quite distinct   
anti-infective proteins in separate crustacean groups. Interestingly, hyastatin seems to owe its 
antibacterial properties to the cysteine-rich C-terminus domain, like crustins [14], because a 
recombinant protein lacking the cysteine-rich domain has no bactericidal activity [16]. However, as 
mentioned earlier when considering conventional, amino acid enriched AMPs, the chitin-binding 
properties may indicate that the peptide is multifunctional. Nature thus seems to ‘mix and match’ Mar. Drugs 2010, 8        
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useful domains to create AMPs that could have dual mechanisms to destroy their targets. The 
possibility remains that synthetic anti-infectives might be designed and engineered that are also 
chimeric but use structures known to have particular efficacy against certain types of pathogen to 
maximize killing and reduce the risk of resistance.  
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